Treatment of Failed Carpal Tunnel Syndrome by Dorsal Ulnar Artery Perforator Adipofascial Flap
NCT06324617 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-03-22
Summary
Carpal tunnel syndrome (CTS) is the most common compressive neuropathy in the general population. Surgical treatment by open or endoscopic carpal tunnel release (CTR) is the first choice of treatment and has clinical success rates of 75% to 90%.The rate of recurrence after primary median nerve release is 3-19% \[1,2\]. Between 0.3% and 12% of cases require surgical revision \[2,3\]. The risk factors for surgical revision for secondary release are male gender, staged or simultaneous bilateral carpal tunnel release, endoscopic release, smoking and rheumatoid arthritis.
Treatment failures after primary CTR are classified as persistent CTS, recurrent CTS, or new symptoms. Recurrent symptoms are uncommon and are defined by a symptom-free interval after surgery. Persistent symptoms are relatively common, particularly in elderly patients and in patients with concurrent nerve compression or medical conditions that affect nerve function, such as diabetes. Persistent or recurrent CTS principally results from incomplete release of the transverse carpal ligament but may be accompanied by perineural scarring, leading to compression or tethering of the median nerve.
New symptoms may be caused by iatrogenic nerve injury. Surgical treatment of recurrent or persistent CTS after primary CTR usually involves open revision CTR, extended proximally into unscarred tissue, and has also included internal or external neurolysis. Unsatisfactory results following revision CTR are common.
A second compression site, or double-crush syndrome, may clinically present as RCTS or PCTS . Thorough preoperative clinical examination may uncover signs of a second compression site, which can then be confirmed on electroneuromyography (ENMG) of the entire arm.
To improve outcomes of revision CTR, recent studies have emphasized the importance of median nerve coverage by well-vascularized soft tissue to enhance nerve healing, to prevent tethering in surrounding scar tissue, and to optimize nerve gliding in the carpal tunnel. Several local flaps (hypothenar fat pad flap, tenosynovial flap), regional flaps (posterior interosseous artery flap, reverse radial artery fascial flap, flexor digitorum superficialis flap), and free flap techniques have been described, but consensus for specific flap has not been reached. Following potential iatrogenic median nerve injury and reexploration for a painful neuroma incontinuity, flap coverage may also be beneficial.
In 1988, Becker and Gilbert introduced a Fasciocutaneous pedicled flap based on a consistent dorsal perforator of the ulnar artery (absent in 1 % of population) named the dorsal ulnar artery (DUA) flap or simply the Becker flap. The authors described open revision CTR with nerve coverage by a DUA flap in 3 patients with recurrent CTS and reported good results as well as a quick and easy-to-perform dissection with low donor site morbidity and preservation of the radial andulnar artery. Since this introduction, additional studies describing fasciocutaneous DUA flaps have mostly focused on its use for reconstruction of hand or wrist wounds. Despite the original described benefits, additional studies of DUA flaps for the treatment of recurrent or persistent CTS have remained limited.
Conditions
- Failed Carpal Tunnel Syndrome Surgery
Interventions
- PROCEDURE
-
Treatment of failed carpal tunnel syndrome by dorsal ulnar artery perforator adipofascial flap
Treatment of failed carpal tunnel syndrome by dorsal ulnar artery perforator adipofascial flap The previous incision is reopened and extended, Neurolysis begins proximally preserving the palmar cutaneous branch. The subcutaneous tissue is exposed, leaving part of the superficial venous plexus with the adipofascial flap. Flap elevation is begun by incising the subcutaneous tissue through the deep fascia along the radial border of FCU and ECU . When the flap reaches a suitable length (10-12 cm from the wrist), it is cut proximally and along the ulnar side. The flap is dissected proximally to distally in continuity with the underlying fascia . When the dissected flap is (2-5) cm proximal to the wrist. Ulnar retraction of the flexor carpi ulnaris permits identification of the perforator. the pivot point of the flap is localized (2-5) cm proximal to the pisiform. The adipofascial flap is turned 180 degrees and anchored with a few absorbable stitches around the median nerve.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-12-30
- Completion
- 2025-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
A Comparison of Incisionless Ultrasound Guided Thread Carpal Tunnel Release and Mini Open Carpal in Patients With Bilateral Carpal Tunnel Syndrome
NCT03906604 ·Status: TERMINATED ·Phase: NA
-
Hydrodissection in Carpal Tunnel Syndrome
NCT07207460 ·Status: COMPLETED ·Phase: NA
-
Carpal Tunnel Release Via Two Small Incisions Comparing With Via Standard Incision And Under Endoscope
NCT02500355 ·Status: COMPLETED ·Phase: NA
-
Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome
NCT06243848 ·Status: RECRUITING ·Phase: NA
-
The Effect of Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome
NCT02809261 ·Status: COMPLETED ·Phase: NA
-
Effect Of Complete Decongestive Therapy On Carpal Tunnel Syndrome Post Upper Limb Lymphedema
NCT05932381 ·Status: UNKNOWN ·Phase: NA
-
Percutaneous Needle Electrolysis Versus Surgery in the Treatment of Carpal Tunnel Syndrome
NCT04216147 ·Status: COMPLETED ·Phase: NA
-
Patient Outcomes With Endoscopic Versus Open Carpal Tunnel Release
NCT00880295 ·Status: COMPLETED ·Phase: NA
-
Comparison of Difference Hydrodissection for CTS
NCT03031041 ·Status: COMPLETED ·Phase: NA
-
The Volume Effect of Nerve Hydrodissection for Carpal Tunnel Syndrome
NCT03381521 ·Status: COMPLETED ·Phase: NA
-
Combined Effect of Insulin and Sodium Hyaluronate Injection Guided by Ultrasound in Carpal Tunnel Syndrome
NCT04142411 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Blood Flow Restriction on Pain Perception, Grip Strength and Nerve Conductivity in CTS Patients.
NCT06574841 ·Status: RECRUITING ·Phase: NA
-
Minimal Invasive Carpal Tunnel Release With the Novel Device
NCT05067205 ·Status: COMPLETED ·Phase: NA
-
Ultrasound Guided - Incisionless Threaded Carpal Tunnel Release
NCT04101955 ·Status: COMPLETED ·Phase: NA
-
Added Value of Ultrasonography in the Diagnosis, Management, and Follow-Up of Carpal Tunnel Syndrome
NCT06834061 ·Status: RECRUITING
-
The Effect of Hyaluronic Acid for Carpal Tunnel Syndrome
NCT03031054 ·Status: COMPLETED ·Phase: NA
-
Ultrasound-Guided Curved Needle Thread Carpal Tunnel Release: Efficacy and Safety of a Single-Center, Single-Arm Clinical Trial
NCT06440070 ·Status: RECRUITING ·Phase: NA
-
A Single-portal Endoscopic Approach Through Subcutaneous Tunnel for Carpal Tunnel Release
NCT05094778 ·Status: COMPLETED ·Phase: NA
-
Appropriateness of Carpal Tunnel Syndrome Management Compared With the AAOS Appropriate Use Criteria
NCT05275816 ·Status: UNKNOWN
-
Sonographic Follow-up of Patients With Carpal Tunnel Syndrome Undergoing Surgical or Conservative Treatment
NCT00694265 ·Status: COMPLETED
-
Comparison of Focused and Radial Extracorporeal Shock Wave for Carpal Tunnel Syndrome
NCT03671473 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Hydrodissection for Carpal Tunnel Syndrome
NCT02991001 ·Status: COMPLETED ·Phase: NA
-
Comparative Outcomes of Endoscopic and Open Carpal Tunnel Release with Neurotrophic Supplementation in Severe Carpal Tunnel Syndrome
NCT06902831 ·Status: COMPLETED
-
Efficacy of Extracorporeal Shock Wave Therapy on Carpal Tunnel Syndrome Post Mastectomy Lymphedema
NCT06131515 ·Status: RECRUITING ·Phase: NA
-
Pulsed Radiofrequency Versus Hyaluronidase Hydrodissection for Treatment of Carpal Tunnel Syndrome
NCT07269613 ·Status: NOT_YET_RECRUITING ·Phase: NA